Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alexander Malugin

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Molecular Pharmaceutics|June 29, 2013
Transcriptional responses of human aortic endothelial cells to nanoconstructs used in biomedical applicationsPhilip J Moos, Matthew Honeggar, Alexander Malugin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 13, 2011
Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapyKhaled Greish, Abhijit Ray, Hillevi Bauer, et al.
Molecular Pharmaceutics|May 24, 2011
Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugatesAbhijit Ray, Nate Larson, Daniel B Pike, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Molecular Pharmaceutics|June 29, 2013
Transcriptional responses of human aortic endothelial cells to nanoconstructs used in biomedical applicationsPhilip J Moos, Matthew Honeggar, Alexander Malugin, et al.
Journal of Controlled Release : Official Journal of the Controlled Release Society|January 13, 2011
Anticancer and antiangiogenic activity of HPMA copolymer-aminohexylgeldanamycin-RGDfK conjugates for prostate cancer therapyKhaled Greish, Abhijit Ray, Hillevi Bauer, et al.
Molecular Pharmaceutics|May 24, 2011
Comparison of active and passive targeting of docetaxel for prostate cancer therapy by HPMA copolymer-RGDfK conjugatesAbhijit Ray, Nate Larson, Daniel B Pike, et al.
Pageof 2